Leonie Wagner (born Hattler) studied Pharmacy at Univeristy of Basel. After graduating as a pharmacist she started her PhD thesis in 2014 in Prof. Dr. Jörg Huwyler’s Group in the field of Pharmaceutical Technology. In 2017 she completed the thesis with the title “Oral formulation for children - The microstructure of functionalized calcium carbonate as key characteristic to develop age-appropriate and compliance enhanced formulations”. Since December 2017 she is working as a formulation scientist at F-Hoffmann-La Roche in R&D Oral dosage forms developing formulations for early clinical phases up to market formulation.
Publications:
W. Moser et al., “Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study,” Lancet Infect. Dis., vol. 16, no. 1, pp. 53–60, Jan. 2016. (mentioned in acknowledgments for developing the tablets)
L. Wagner-Hattler, J. Schoelkopf, J. Huwyler, and M. Puchkov, “Characterization of new functionalized calcium carbonate-polycaprolactone composite material for application in geometry-constrained drug release formulation development,” Drug Dev. Ind. Pharm., vol. 43, no. 10, pp. 1669-1676, Oct. 2017.
L. Wagner-Hattler, K. Wyss, J. Schoelkopf, J. Huwyler, and M. Puchkov, “Mouthfeel Study of Functionalized Calcium Carbonate in Orally Disintegrating Tablets” Int. J. Pharm., vol. 534, no. 1, pp. 50–59, Dec. 2017.
L. Wagner-Hattler, J. Schoelkopf, J. Huwyler, and M. Puchkov. "Stability Investigation of Fcc-Based Tablets for Oral Suspension with Caffeine and Oxantel Pamoate as Model Drugs." Drug Dev. Ind. Pharm., vol. 0, no. 0, pp. 1-9, Oct. 2018.